6 minute read
Nov. 16, 2023

GNE-7883: Proof-of-Concept for TEAD and RAS Inhibitor Synergy

GNE-7883

pan-TEAD inhibitor preclinical efficacy in xenograft models from TEAD3-YAP HTS of >2M cmpds + opt. Nature, June 5, 2023 Genentech, South San Francisco, CA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in